In millions, except per share items | Dec-31-08 | Dec-31-07 | Dec-31-03 | Dec-31-02 | Dec-31-01 |
Revenues | 32.1 | 29.9 | 14.1 | 13.0 | 15.6 |
Revenue growth | 7.5% | | 8.7% | -16.6% | |
Cost of goods sold | 20.8 | 20.9 | 11.2 | 11.2 | 11.3 |
Gross profit | 11.3 | 9.0 | 2.9 | 1.8 | 4.3 |
Gross margin | 35.3% | 30.2% | 20.9% | 14.1% | 27.5% |
Sales and marketing | 4.0 | 4.6 | 2.8 | 3.5 | 4.5 |
Research and development | 3.0 | 3.2 | 3.7 | 6.2 | 5.5 |
General and administrative | 7.8 | 6.2 | 4.6 | 5.5 | 7.8 |
EBITA | -3.4 | -5.0 | -8.1 | -13.3 | -13.5 |
EBITA margin | -10.6% | -16.9% | -57.4% | -102.6% | -86.5% |
Amortization of intangibles | 1.1 | 1.3 | 0.3 | 0.3 | 0.7 |
EBIT | -4.5 | -6.3 | -8.4 | -13.7 | -14.2 |
EBIT margin | -14.0% | -21.1% | -59.7% | -105.2% | -90.9% |
Pre-tax income | -10.7 | -9.0 | -11.7 | -15.5 | -14.5 |
Income taxes | -0.4 | -0.4 | -0.1 | 0.0 | -0.8 |
Tax rate | 3.4% | 4.9% | 0.6% | 0.0% | 5.5% |
Earnings from continuing ops | -10.4 | -8.6 | -11.7 | -15.5 | -13.7 |
Earnings from discontinued ops | 0.1 | 0.1 | | | |
Net income | -10.3 | -8.5 | -11.7 | -15.5 | -13.9 |
Net margin | -32.0% | -28.3% | -82.5% | -119.4% | -89.0% |
|
Diluted EPS | ($0.27) | ($0.25) | ($0.85) | ($1.22) | ($1.28) |
Shares outstanding (diluted) | 38.5 | 34.9 | 13.7 | 12.7 | 10.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |